Cargando…
SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy
SIMPLE SUMMARY: Patients with pancreatic ductal adenocarcinoma (PDAC) are increasingly receiving neoadjuvant therapy (NAT) with the aim of improving patient care. However, complete tumor regression remains rare, and there is a dire need for biomarkers that can predict responses to NAT. SMAD4 is a pr...
Autores principales: | Racu, Marie-Lucie, Bernardi, Dana, Chaouche, Aniss, Zindy, Egor, Navez, Julie, Loi, Patrizia, Maris, Calliope, Closset, Jean, Van Laethem, Jean-Luc, Decaestecker, Christine, Salmon, Isabelle, D’Haene, Nicky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417261/ https://www.ncbi.nlm.nih.gov/pubmed/37568581 http://dx.doi.org/10.3390/cancers15153765 |
Ejemplares similares
-
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
por: Racu, Marie-Lucie, et al.
Publicado: (2022) -
Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report
por: Verocq, Camille, et al.
Publicado: (2021) -
VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013) -
SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature
por: Lebrun, Laetitia, et al.
Publicado: (2023) -
What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)